| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 08/25/2005 | US20050187213 A ready-to-use two-component pharmaceutical comprising meloxicam or a pharmaceutically salt and a pharmaceutically carrier and an antibiotic of beta -lactams, quinolones, tetracyclines, sulfonamides, fenicoles, and/or macrolides and a pharmaceutically carrier; veterinary medicine. |
| 08/25/2005 | US20050187205 Pyrrolidineacetamide derivative alone or in combination for treatment of CNS disorders |
| 08/25/2005 | US20050187200 Methods and reagents for the treatment of inflammatory disorders |
| 08/25/2005 | US20050187194 fructose 1,6-bisphosphatase (FBPase) inhibitors for diabetic complications, hyperlipidemia, hypertension, arteriosclerosis, macroangiopathy; 2-amino-5-isobutyl-4-{2-[5-(N,N'-bis((S)-1-ethoxycarbonyl)ethyl)phosphonamido]furanyl}thiazole |
| 08/25/2005 | US20050187184 Administering CCI-779 [or 42-O-(2-hydroxy)ethyl rapamycin] and an aromatase inhibitor such as letrozole; therapy of neoplasms; useful in the treatment of renal cancer, soft tissue cancer, breast cancer, neuroendocrine tumor of the lung, cervical cancer, uterine cancer, head and neck cancer |
| 08/25/2005 | US20050187180 Induction of viral mutation by incorporation of miscoding ribonucleoside analogs into viral RNA |
| 08/25/2005 | US20050187179 treatment of tumors which have increased Notch expression; administration of either Notch antisense oligonucleotides or monoclonal antibodies directed to Notch along with cell differentiating agent |
| 08/25/2005 | US20050187172 Combination of a Cox-2 inhibitor and a DNA topoisomerase I inhibitor for treatment of neoplasia |
| 08/25/2005 | US20050187157 Pharmaceutical compositions based on anticholinergics and pegsunercept |
| 08/25/2005 | US20050187148 Antitumor agent |
| 08/25/2005 | US20050187144 Combinations of chromium or vanadium with antidiabetics for glucose metabolism disorders |
| 08/25/2005 | US20050186665 Expressed ligand - vascular intercellular signaling molecule |
| 08/25/2005 | US20050186650 Pharmaceuticals and methods for treating hypoxia and screening methods therefor |
| 08/25/2005 | US20050186571 Diagnosis and prevention of cancer cell invasion |
| 08/25/2005 | US20050186568 Enzymatic polypeptides for use as drug screening tools; pharmacological toxicity |
| 08/25/2005 | US20050186567 Antisense modulation of peroxisome proliferator-activated receptor gamma expression |
| 08/25/2005 | US20050186559 Identifying Amyloid precurser protein lowering agents; non-steroidal anti-inflammatory drug (NSAID); Alzheimer's disease |
| 08/25/2005 | US20050186526 Methods and systems for enabling and stabilizing tooth movement |
| 08/25/2005 | US20050186289 Regulation of T cell-mediated immunity by D isomers of inhibitors of indoleamine-2,3-dioxygenase |
| 08/25/2005 | US20050186288 Compositions and methods for the prophylaxis and treatment of aphthous ulcers and herpes simplex lesions |
| 08/25/2005 | US20050186265 Negatively charged first lipid; barium, calcium, zinc, magnesium and/or cation; carbohydrates, vitamins, minerals, polynucleotides, polypeptides, lipids, flavors and drugs; particle sizes; storage stability, oxidation resistance, dimensional stability; |
| 08/25/2005 | US20050186250 Metallic structures incorporating bioactive materials and methods for creating the same |
| 08/25/2005 | US20050186211 Use of mda-5 as an antiviral and antiproliferative agent |
| 08/25/2005 | US20050186208 Anti-neoplastic composition of adrenocorticosteroides, progestins, estrogens, antiestrogen, androgens; breast cancer, colorectal cancer, rectal cancer, non-small cell lung cancer, non-Hodgkins lymphoma (NHL), renal cell cancer, prostate cancer, liver cancer, pancreatic cancer, soft-tissue sarcoma |
| 08/25/2005 | US20050186205 Administering unlabelled anti-CD20 antibody that binds to the CD20 antigen present on lymphoma cells; a second treatment of cyclophosphamide, doxorubicin, vincristine or prednisone |
| 08/25/2005 | US20050186189 Treating obesity |
| 08/25/2005 | US20050186188 Compositions containing probiotics and polysaccharides and methods of use |
| 08/25/2005 | US20050186183 Stabilized products, processes and devices for preparing same |
| 08/25/2005 | US20050186180 Recombinant virus encoding an antigen of a disease state; second recombinant virus encoding an immunostimulatory molecule with an exogenous immunostimulatory molecule, chemotherapeutic drug, antibiotic, antiviral drug or antifungal drug. |
| 08/25/2005 | US20050186175 such as etanercept and said ester anticholinergic e.g. scopine 2,2-diphenylpropionic acid ester methobromide; treating inflammatory or obstructive respiratory system disorders such as asthma or chronic obstructive pulmonary disease (COPD); inhalants |
| 08/25/2005 | US20050184427 casting matrices comprising a mixture of polymers, solvents and active components selected from drugs, flavors, fragrances, enzymes, preservatives, sweetners, colorants, spices or vitamins, onto wells and drying by applying of heat to form a film dosage unit |
| 08/25/2005 | DE102004006829A1 Cosmetic composition for e.g. preventing or treating acne or sebum production contains actives combination of isoflavones and antiperspirants |
| 08/25/2005 | CA2558879A1 Regulatory cell controlling immunological activity of t cell |
| 08/25/2005 | CA2556601A1 The use of o-atp for the treatment of diseases involving angiogenesis |
| 08/25/2005 | CA2556256A1 Method and compositions for treatment of painful disorders |
| 08/25/2005 | CA2555811A1 Methods for treating resistant or refractory tumors |
| 08/25/2005 | CA2555099A1 Alcohol metabolism moderating composition |
| 08/25/2005 | CA2554664A1 Complexed polypeptide and adjuvant for improved vaccines |
| 08/25/2005 | CA2554271A1 Combination of proton pump inhibitor, buffering agent, and nonsteroidal anti-inflammatory agent |
| 08/25/2005 | CA2553748A1 Composition and method for use in cartilage affecting conditions |
| 08/24/2005 | EP1566202A1 Use of resistin antagonists in the treatment of rheumatoid arthritis |
| 08/24/2005 | EP1566184A1 Remedy for corneal failure |
| 08/24/2005 | EP1565581A2 Compositions, kits, and methods for identification, assessment, prevention, and therapy of cervical cancer |
| 08/24/2005 | EP1565547A2 Probiotic strains, a process for the selection of them, compositions thereof, and their use |
| 08/24/2005 | EP1565489A2 Novel raag10 cell surface target and a family of antibodies recognizing that target |
| 08/24/2005 | EP1565230A2 Material compositions and related systems and methods for treating cardiac conditions |
| 08/24/2005 | EP1565215A2 Use of the corticoliberin-urocortin system in the treatment of inflammatory diseases |
| 08/24/2005 | EP1565212A1 Gastrin compositions and formulations, and methods of use and preparation |
| 08/24/2005 | EP1565199A2 Therapeutic polypeptides,nucleic acids encoding same, and methods of use |
| 08/24/2005 | EP1565193A2 Methods and compositions for treating cancer using proteasome inhibitors |
| 08/24/2005 | EP1565192A2 Method and compositions for temporarily incapaciting subjets |
| 08/24/2005 | EP1565188A2 Methods for the treatment, prevention and management of macular degeneration |
| 08/24/2005 | EP1565185A2 Neuroprotective iron chelators and pharmaceutical compositions comprising them |
| 08/24/2005 | EP1565181A2 Deguelin as a chemopreventive agent for lung cancer |
| 08/24/2005 | EP1565178A2 Method and compositions for treating persistent pulmonary hypertension using aralkyl ester soft drugs |
| 08/24/2005 | EP1497289B1 Medicaments containing betamimetic drugs and a novel anticholinesterase drug |
| 08/24/2005 | EP1478770A4 Screening method for orthopoxvirus antivirals |
| 08/24/2005 | EP1370558B1 Piperazine- and piperidine-derivatives as melanocortin receptor agonists |
| 08/24/2005 | EP1356733B1 Pesticidal and antiparasitic compositions |
| 08/24/2005 | EP1353927B1 Sulfamidothienopyrimidines and the use of the same as phosphodiesterase v inhibitors |
| 08/24/2005 | EP1343789B1 Tricyclic derivatives of indole with antiangiogenic activity |
| 08/24/2005 | EP1286975B1 Biclyclic cyclohexylamines and their use as nmda receptor antagonists |
| 08/24/2005 | EP1242085B1 Benzimidazole compounds having nociceptin receptor affinity |
| 08/24/2005 | EP1204426B1 Medical preparation for treating arthrosis, arthritis and other rheumatic joint diseases |
| 08/24/2005 | EP1190248B1 Screening methods for compounds which affect melanogenesis |
| 08/24/2005 | EP1146859B1 Method of preparing particles for agglomeration |
| 08/24/2005 | EP1144394B1 1-heterocycle substituted diarylamines |
| 08/24/2005 | EP1019075B1 Beta 2-adrenergic receptor agonists |
| 08/24/2005 | EP0914102B1 Compositions and methods for treating or preventing diseases of body passageways |
| 08/24/2005 | EP0856315B1 Protein-farnesyltransferase inhibitors in combination with hmgcoa-reductase-inhibitors for the treatment of aids |
| 08/24/2005 | CN1659147A Pyridazine derivatives |
| 08/24/2005 | CN1659143A Nitrogen-containing heteroaryl compounds having HIV integrase inhibitory activity |
| 08/24/2005 | CN1659136A Novel sodium channel blockers |
| 08/24/2005 | CN1658904A Combinations comprising epothilones and pharmaceutical uses thereof |
| 08/24/2005 | CN1658903A Combinations of peroxisome proliferator-activated receptor (ppar) activator(s) and sterol absorption inhibitor(s) and treatments for vascular indications |
| 08/24/2005 | CN1658901A Methods for treating TWEAK-related conditions |
| 08/24/2005 | CN1658897A Methods for treating muscle injuries |
| 08/24/2005 | CN1658895A Use of osteoprotegerin for the prevention and/or treatment of fibrosis/sclerosis |
| 08/24/2005 | CN1658894A Methods and compositions for the treatment of eye diseases |
| 08/24/2005 | CN1658888A Quaternised ammonium cyclodextrin compounds |
| 08/24/2005 | CN1658884A Dihydrate dehydroepiandrosterone and methods of treating asthma or chronic obstructive pulmonary disease using compostions thereof |
| 08/24/2005 | CN1658883A Methods for increasing the therapeutic response to electroconvulsive therapy |
| 08/24/2005 | CN1658874A (1-4-piperidinyl) benzimidazole derivatives useful as histamine H3 antagonists |
| 08/24/2005 | CN1658873A New pharmaceutical compositions based on anticholinergics and p38 kinase inhibitors |
| 08/24/2005 | CN1658871A Amide derivatives as GK activators |
| 08/24/2005 | CN1658869A N- ((3-oxo2, 3-dihydro-1H-isoindol-1-yl) acetyl) guanidine derivatives as NHE-1 inhibitors for the treatment of infarction and angina pectoris |
| 08/24/2005 | CN1658867A Use of substituted cyanopyrrolidines and combination preparations containing them for treating hyperlipidemia and associated diseases |
| 08/24/2005 | CN1658859A Therapeutic agent for overactive bladder |
| 08/24/2005 | CN1658848A Methods for identification of modulators of angiogenesis, compounds discovered thereby, and methods of treatment using the compounds |
| 08/24/2005 | CN1658847A Use of EP4 receptor ligands in the treatment of IL-6 involved diseases |
| 08/24/2005 | CN1658845A Stealth lipid nanocapsules, methods for the preparation thereof, and use thereof as a carrier for active principle(s) |
| 08/24/2005 | CN1658839A Dry powder compositions |
| 08/24/2005 | CN1658836A Processes for forming a drug delivery device |
| 08/24/2005 | CN1658834A Method of treating mucus hypersecretion |
| 08/24/2005 | CN1658828A Gallocatechin gallate-containing composition |
| 08/24/2005 | CN1658767A Composition for modulating a physiological reaction or inducing an immune response |
| 08/24/2005 | CN1657100A Nano-class preparation for selective target stomach cancer-and lymph system and its preparation method |
| 08/24/2005 | CN1657099A Preparation method of ultra paramagnetic particle iodized oil suspension |
| 08/24/2005 | CN1215837C Ibuprofen solutions for capsule-filling and capsule preparations |
| 08/24/2005 | CN1215834C Emulsion of perfluororganic compounds for medical purposes, method for producing said emulsion and methods for curing and preventing diseases with the aid of the emulsion |